Literature DB >> 19230152

The pandemic influenza vaccine challenge.

Marie Paule Kieny, Keiji Fukuda.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 19230152     DOI： 10.1016/j.vaccine.2008.07.046

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  5 in total

Review 1.  Considerations of strategies to provide influenza vaccine year round.

Authors:  Philipp Lambach; Alba Maria Ropero Alvarez; Siddhivinayak Hirve; Justin R Ortiz; Joachim Hombach; Marcel Verweij; Jan Hendriks; Laszlo Palkonyay; Michael Pfleiderer
Journal:  Vaccine       Date:  2015-08-28       Impact factor: 3.641

2.  Glycyrrhizin exerts antioxidative effects in H5N1 influenza A virus-infected cells and inhibits virus replication and pro-inflammatory gene expression.

Authors:  Martin Michaelis; Janina Geiler; Patrizia Naczk; Patchima Sithisarn; Anke Leutz; Hans Wilhelm Doerr; Jindrich Cinatl
Journal:  PLoS One       Date:  2011-05-17       Impact factor: 3.240

3.  Effects of flavonoid-induced oxidative stress on anti-H5N1 influenza a virus activity exerted by baicalein and biochanin A.

Authors:  Martin Michaelis; Patchima Sithisarn; Jindrich Cinatl
Journal:  BMC Res Notes       Date:  2014-06-23

4.  Glycyrrhizin inhibits highly pathogenic H5N1 influenza A virus-induced pro-inflammatory cytokine and chemokine expression in human macrophages.

Authors:  Martin Michaelis; Janina Geiler; Patrizia Naczk; Patchima Sithisarn; Henry Ogbomo; Behric Altenbrandt; Anke Leutz; Hans Wilhelm Doerr; Jindrich Cinatl
Journal:  Med Microbiol Immunol       Date:  2010-04-13       Impact factor: 3.402

5.  Controlling epidemics with transmissible vaccines.

Authors:  Scott L Nuismer; Ryan May; Andrew Basinski; Christopher H Remien
Journal:  PLoS One       Date:  2018-05-10       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.